Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 August - 2 Septemb
During its September meeting, the European Medicines Agency's (EMA)Pharmacovigilance Risk Assessment Committee (PRAC) discussed one ongoing safetyreferral. It did not initiate or conclude a referral.
Click on this link for more information.
